Mirabegron ER 50 mg & Solifenacin succinate 5 mg .. .

MIRAGRON S 50/5 
Mirabegron (ER) (50mg) and Solifenacin succinate (5mg)
Mirabegron (ER) (50mg) and Solifenacin succinate (5mg) are medications often prescribed in combination to treat overactive bladder (OAB) in adults. The "ER" in Mirabegron (ER) indicates that it is an extended-release formulation, designed to provide a more sustained release of the medication over time. Here's some information about each of these medications and their combination:

Mirabegron (ER) (50mg):

Mirabegron is a medication used to treat OAB. It is classified as a beta-3 adrenergic agonist.
The "ER" formulation means that it is an extended-release version of Mirabegron, allowing for more continuous release of the medication over the course of the day.
Mirabegron works by relaxing the bladder muscle, increasing bladder capacity, and reducing the symptoms of OAB, such as urinary urgency and frequency.
Solifenacin Succinate (5mg):

Solifenacin is an anticholinergic medication used to treat OAB. It is often sold under the brand name Vesicare.
Solifenacin works by blocking certain neurotransmitters in the bladder, leading to reduced bladder muscle contractions and improved bladder control.
The combination of Mirabegron (ER) and Solifenacin succinate is often prescribed to provide more comprehensive relief of OAB symptoms. By using both medications, patients may experience reduced urgency, frequency, and urinary incontinence associated with OAB.

Here are some key points to consider:

Prescription Requirement: Both MIRAGRON S 50/5  are prescription medications, and their use should be overseen by a healthcare provider.

Dosage: The dosages of these medications may vary depending on the specific formulation and the patient's response to treatment. The combination product you mentioned contains 50mg of Mirabegron (ER) and 5mg of Solifenacin succinate, which is a common combination.

Effectiveness: This combination of medications can be highly effective in managing OAB symptoms. It provides dual mechanisms of action to control bladder muscle activity and reduce symptoms like urgency and incontinence.

Side Effects: Common side effects of these medications may include dry mouth, constipation, blurred vision, and urinary retention. As with any medication, individual responses to side effects can vary.

Precautions: It's important to discuss your medical history and any other medications you are taking with your healthcare provider to ensure that this combination is safe and appropriate for your specific situation.

If you have been prescribed the combination of Mirabegron (ER) (50mg) and Solifenacin succinate (5mg) for the treatment of overactive bladder, it's crucial to follow your healthcare provider's recommendations regarding the dosage and duration of treatment. They can provide guidance on whether this combination is suitable for your specific condition and address any questions or concerns you may have about the medication.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
sterisonline.com